Overview

The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Non-steroidal Anti-inflammation Drugs can effectively reduce the lower urinary tract symptoms from benign prostatic hyperplasia
Phase:
Phase 4
Details
Lead Sponsor:
Samsung Medical Center
Collaborator:
The Korean Urological Association
Treatments:
Adrenergic alpha-Antagonists
Alfuzosin
Anti-Inflammatory Agents, Non-Steroidal
Celecoxib
Doxazosin
Prazosin
Tamsulosin
Terazosin